Biotech · Private company
Newron Pharmaceuticals SPA
Track this companyFree. Adds Newron Pharmaceuticals SPA to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Evenamide 15 mg bidPhase 3 · Treatment-resistant SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Sarizotan high dosePhase 3 · Rett SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Sarizotan low dosePhase 3 · Rett SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- EvenamidePhase 2 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant SchizophreniaPHASE3 · RECRUITING · started Jan 23, 2026ClinicalTrials.gov NCT07184619 · fetched Nov 12, 2026
- Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic SchizophreniaPHASE2 · COMPLETED · started Jun 16, 2020ClinicalTrials.gov NCT04461119 · fetched Nov 12, 2026
- Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory SymptomsPHASE2_PHASE3 · TERMINATED · started Oct 26, 2016ClinicalTrials.gov NCT02790034 · fetched Nov 12, 2026